Indeed, HLA-DRB1 genetic variants have long been established to confer that magnitude of risk but are not used to screen the population because carriage of the variants only increases risk from 1% to 3% (i.e. 97% risk of not developing RA). This evidence concerns the gene HLA-DRB1 and rheumatoid arthritis.